Premium
In Case You Haven't Heard…
Publication year - 2020
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32919
Subject(s) - digital health , internet privacy , cloud computing , confidentiality , suite , service (business) , computer security , health care , computer science , business , sociology , law , political science , marketing
Digital therapeutics — it sounds like something useful for people with privacy issues. But it's powered by Google Cloud, so one wonders. Developed by Orexo (which makes a form of buprenorphine) and Accenture, the digital therapeutic, called “vorvida,” is a digital platform that uses the INTIENT Patient solution suite to help patients with problematic alcohol use. It connects to “an ecosystem of third‐party health care services,” according to the press release that came out this month. “We are delighted to work with Accenture to make our digital therapies even more accessible to those who need them,” said Dennis Urbaniak, executive vice president of digital therapeutics at Orexo. “We know that many of our patients are concerned with confidentiality and privacy, and the INTIENT™ Platform provides a safe, secure platform through which individuals struggling with mental or behavioral issues can confidently get the care they need — right at their fingertips.” “Orexo is a great example of how INTIENT™ is supporting the future of the life science industry, driven by a focus on New Science, by providing a secure digital solution for patient data and connectivity to the market of digital health innovations and services,” said Tony Romito, managing director of global patient service at Accenture.